Intentionally developed to help protect against thrombotic events, providing unique versatility across the broadest range of patients in its class

  • Largest clinical development program of its class with more than 20 RCTs and 120,000-plus patients7-27
  • Dosing regimens optimized for each therapeutic indication
  • Proven efficacy and safety profile across the most indications — NVAF, CAD, PAD, DVT/PE initial and extended treatment, and VTE prophylaxis in acutely ill medical patients and after hip/knee replacement surgery

Need Help?